Review Article
The Role of Three-Dimensional Scaffolds in Treating Long Bone Defects: Evidence from Preclinical and Clinical Literature—A Systematic Review
Table 1
Complete details of 12 preclinical papers identified in this systematic review focusing on the usefulness of scaffolds alone in treating long bone defects.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
HA: hydroxyapatite, HA-TCP: hydroxyapatite-tricalcium phosphate, Si-TCP: silicon stabilized tricalcium phosphate, HA-PE: hydroxyapatite-polyethylene, HA-COL: hydroxyapatite-collagen, HA-COL-CS: hydroxyapatite-collagen-chondroitin sulphate, HASi: calcium silicate, tricalcium phosphate, and hydroxyapatite, mPCL-TCP: medical grade polycaprolactone-tricalcium phosphate, (PLDLLA)- TCP-PCL: poly(L-lactide-co-D,L-lactide)- polycaprolactone-tricalcium phosphate, ABG: autologous bone graft, PCL-Coll I-CS: polycaprolactone-collagen- chondroitin sulphate, HA-alumina: hydroxyapatite-alumina, Baghdadite: Ca3ZrSi2O9, Baghdadite-PCL-nBG: Ca3ZrSi2O9-polycaprolactone-bioactive glass nanoparticles, SEM: scanning electron microscopy, BSE: backscattered electron imaging, Hist: histological analysis, µCT: microcomputed tomography, Mech: mechanical analysis, X-ray: radiological analysis, +: positive effects, −: negative effects, and : no significant difference. |